Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,092,386 | 1,218,273 | 1,439,415 | 123,316 | 135,227 |
| Marketable Securities | 1,129,705 | 1,520,645 | 542,805 | 600,944 | 613,310 |
| Receivables | 312,243 | 167,252 | 127,777 | 77,913 | 46,074 |
| Inventories | 100,176 | 49,076 | 25,371 | 20,242 | 24,404 |
| Income taxes - deferred | 16,415 | 20,506 | 87,979 | 113,059 | 4,082 |
| Other current assets | 190,441 | 108,669 | 87,657 | 37,363 | 26,783 |
| TOTAL | $2,841,366 | $3,084,421 | $2,311,004 | $972,837 | $849,880 |
| Non-Current Assets | |||||
| PPE Net | 248,971 | 197,428 | 146,645 | 77,477 | 53,738 |
| Investments And Advances | 18,392 | 14,422 | 16,379 | 17,017 | 0 |
| Intangibles | 1,023,586 | 131,691 | 139,003 | 130,803 | 150,213 |
| Other Non-Current Assets | 312,955 | 183,322 | 122,760 | 60,179 | 53,462 |
| TOTAL | $1,603,904 | $526,863 | $424,787 | $285,476 | $257,413 |
| Total Assets | $4,445,270 | $3,611,284 | $2,735,791 | $1,258,313 | $1,107,293 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 196,555 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 53,859 | 37,876 | 24,410 | 16,414 | 18,650 |
| Accrued Expenses | 306,120 | 159,220 | 112,992 | 92,908 | 68,534 |
| Other current liabilities | 114,688 | 26,625 | 9,795 | 5,127 | 670 |
| TOTAL | $527,248 | $432,931 | $239,703 | $135,637 | $141,415 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,419 | 7,666 | 7,647 | 6,473 | 6,926 |
| Other Non-Current Liabilities | 423,567 | 274,106 | 456,884 | 427,834 | 414,442 |
| TOTAL | $426,694 | $334,409 | $519,911 | $486,901 | $488,434 |
| Total Liabilities | $953,942 | $767,340 | $759,614 | $622,538 | $629,849 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 918,926 | 807,518 | 755,106 | 689,940 | 661,080 |
| Common Shares | 4,633 | 4,072 | 3,801 | 3,441 | 1,651 |
| Retained earnings | -1,408,993 | 124,660 | -101,773 | -170,754 | -234,410 |
| Other shareholders' equity | -127,709 | 84,363 | 12,260 | 487 | 68,296 |
| TOTAL | $3,491,328 | $2,843,944 | $1,976,177 | $635,775 | $477,444 |
| Total Liabilities And Equity | $4,445,270 | $3,611,284 | $2,735,791 | $1,258,313 | $1,107,293 |